Regular follow-up visits allow the care team to evaluate results, address concerns, and make adjustments to support safe and sustainable weight loss outcomes
While further clinical trials with long-term follow-up periods are still required, ALC appears to be a safe, well-tolerated, and effective potential treatment option for DPN
As we step into a new, more accessible era of anti-obesity care, contributing to a sharper demand for GLP-1s and similar medications, its important that patients, providers and employers understand the key differences between formulations and how they impact health outcomes
Determinants of GH-releasing hormone and GH-releasing peptide synergy in men
Increased apoptosis in a variety of tissues of zinc-deficient rats
Everything is packaged to protect quality